Dr. Adrian Matthew Guevara, MD

Dr. Guevara practices at Epiphany Dermatology PA in Austin, Texas.

Dr. Guevara's NPI, 1104898188, was assigned on February 3, 2006. Dr. Guevara graduated from Joe R. & Teresa Lozano Long School of Medicine in 2001. Dr. Guevara's Texas license number on file is M5195.

Dr. Guevara's primary practice is Epiphany Dermatology PA, at 7300 Ranch Rd 2222, Austin, TX 78730 in Travis County. The practice phone is (254) 537-1265.

Dr. Guevara's primary practice is Epiphany Dermatology PA in Austin, Texas. The medical group on file is Epiphany Dermatology. Dmand AI also links Dr. Guevara to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Guevara practices. Vendor and product names are available with a free account.

Dermatology is Dr. Guevara's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Guevara is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Guevara's licenses on file in 2 states: Texas and Oklahoma.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, corns and calluses, facial skin infection and hives among the conditions Dr. Guevara treats.

CMS data shows 1,809 Medicare services from Dr. Guevara across 20 procedure codes in 2024, for 443 Medicare patients. Medicare paid $213,077 for them. Every service was in an office.

CMS counts 443 Medicare patients who saw Dr. Guevara in 2024. The largest group is 75 to 84, with 165 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Guevara's median patient age at 71, with 49% women.

In 2024, Dr. Guevara wrote 392 Medicare Part D claims for 157 patients. 85% of them were for generic drugs. CMS names the drug for 207 of them, across 8 drugs with 11 or more claims each, at $522,124 in total drug cost. In 2023, CMS named 173 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Guevara for performance year 2024, reported as part of a group. Dr. Guevara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 41 procedures of melanoma (skin cancer) excision by Dr. Guevara, more than 84% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Guevara in 2024. Dr. Guevara's most frequent co-authors are Cary Daniel Chisholm, MD, Aleksi Hendricks, MD and Chad D. Housewright, MD.

CMS Open Payments shows 861 general payments to Dr. Guevara from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Janssen Pharmaceuticals, Inc paid the most, $4,923.

Dmand AI lists 2 awards for Dr. Guevara, most recently CMS Stage 1 EHR in 2013.

Dr. Guevara graduated from Joe R. & Teresa Lozano Long School of Medicine in 2001. Dr. Guevara is a member of ASDS.

Dr. Guevara is in network with 24 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.